News
2424 posts · page 67 of 101
Medical Device Industry Rejects Pharma-Like Regulation in Draft Bill
India's medical device sector opposes the 2026 draft bill, arguing it wrongly equates devices with pharmaceuticals.
Apollo Hospitals Plans Major Expansion with 5,800 New Beds by 2031
Apollo Hospitals aims to add 5,800 beds in five years amid a 21% revenue increase to ₹7,043 crore in Q1 FY27.
Fortis Healthcare Shares Plummet 6% Amid Cost Regulation Proposal
Hospital stocks tumble as a parliamentary panel suggests capping private room rates to three-star hotel tariffs in metros.
Molbio Diagnostics Eyes ₹940 Crore Through IPO Amidst Global Expansion
Molbio Diagnostics plans to raise ₹940 crore via IPO to expand operations and reduce promoter stake.
Medical Device Industry Rejects Draft Bill, Cites Misclassification
India's medical device sector opposes the draft bill treating devices as drugs, citing innovation risks.
Molbio Diagnostics Targets ₹940 Crore in IPO for Expansion and Stake Reduction
Molbio Diagnostics aims to raise ₹940 crore to expand operations and reduce promoter stake through its IPO. The company sees high growth potential in its diagnostic solutions.
Medical Device Industry Challenges Draft Bill Treating Devices as Drugs
India's medical device sector opposes a draft bill that equates devices with drugs, fearing impact on innovation and investment.
Molbio Diagnostics Targets ₹940 Crore in IPO for Expansion and Stake Reduction
Molbio Diagnostics plans to raise ₹940 crore through an IPO to fund expansion and reduce promoter stake, eyeing growth in global diagnostics.
Medical Device Industry Challenges Draft Bill on Regulatory Grounds
India's medical device sector opposes the Draft Bill 2026, arguing it treats devices like drugs, risking innovation and investments.
Molbio Diagnostics Seeks IPO to Fuel Global Expansion Amid Tuberculosis Test Success
Molbio Diagnostics plans to raise ₹940 crore via IPO to expand operations and reduce promoter stake, targeting high-risk investors.
Industry Pushback: Medical Devices Not Pharmaceuticals, Firms Say
Medical device firms oppose India's draft bill equating devices with drugs, citing risks to innovation and investment.
Molbio Diagnostics IPO: A High-Risk Bet for Long-Term Growth?
Molbio Diagnostics plans to raise ₹940 crore through its IPO to fund growth and reduce promoter stake.
India's Medical Device Industry Challenges Draft Bill's Pharma Approach
Medical device firms in India contest the 2026 draft bill treating devices like drugs, fearing it threatens innovation and investment.
Molbio Diagnostics Targets ₹940 Crore in IPO for Expansion
Molbio Diagnostics plans a ₹940 crore IPO to expand its manufacturing and reduce promoter stake.
Medical Device Industry Challenges Draft Bill Treating Devices as Drugs
India's medical device sector opposes a draft bill equating devices with drugs, citing potential harm to manufacturing and innovation.
Molbio Diagnostics Aims for Growth with ₹940 Crore IPO
Molbio Diagnostics plans a ₹940 crore IPO to fund expansion and reduce promoter stake, targeting high-risk investors.
Industry Pushback: Medical Devices Not Pharmaceuticals, Firms Oppose Bill
India's medical device sector opposes a draft bill equating devices with drugs, citing potential harm to innovation and investment.
Molbio Diagnostics Targets ₹940 Crore in IPO to Fuel Growth
Molbio Diagnostics seeks ₹200 crore for capital expansion and plans to reduce promoter stake via a ₹740 crore offer for sale.
Medical Device Industry Opposes Draft Bill Equating Devices with Drugs
India's medical device sector protests the draft bill, arguing it stifles innovation by treating devices like pharmaceuticals.
Molbio Diagnostics IPO: A High-Risk Bet for Long-Term Gains?
Molbio Diagnostics seeks ₹200 crore via IPO for expansion, targets ₹740 crore through promoter stake sale.
India's Medical Device Industry Challenges Draft Bill's Pharma Parallels
Industry voices argue the Draft Bill, equating medical devices with drugs, threatens innovation and investment.
Manipal Health IPO Sees Strong Institutional Demand, Oversubscribed
Manipal Health's IPO was oversubscribed, driven by strong institutional interest despite retail investor caution.
Major Legal Firms Guide Manipal Hospital’s INR 8000 Cr IPO
Leading law firms CAM, Khaitan, Latham, Trilegal, and JSA are advising Manipal Hospital on its INR 8000 crore IPO.
E-Cigarette Flavoring Vanillin Disrupts Stem Cell Development: UCR Study
Research shows vanillin in e-cigarettes impairs human embryonic stem cell growth, raising health concerns.